Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia

Liposomal amphotericin B versus the comb

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction : Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

✍ Gloria N. Mattiuzzi; Elihu Estey; Issam Raad; Francis Giles; Jorge Cortes; Yu Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The authors evaluated the efficacy and toxicity of liposomal amphotericin B (L‐AmB) compar